Why Interoperability Can Influence NHS Adoption
When suppliers think about NHS adoption, the conversation often gravitates towards functionality, user experience, pricing and implementation timescales. These are all important factors, and understandably so, because organisations want confidence that a solution can solve a genuine problem without creating additional operational burden.
However, one area that is frequently underestimated is the influence interoperability can have on adoption, not just during procurement, but throughout the entire lifecycle of a solution.
Many suppliers still view interoperability as a technical consideration that comes into play after a contract has been awarded. The assumption is often that if a product is good enough, and if the clinical or operational need is strong enough, then any necessary interfaces can be developed later. While this approach might seem reasonable from a product perspective, it often overlooks how NHS organisations evaluate risk, assess operational impact and make decisions about long-term sustainability.
The reality is that NHS organisations rarely purchase systems in isolation. Even relatively small solutions frequently need to exchange information with EPRs, departmental applications, regional platforms, diagnostic systems, clinical portals, shared care records and a growing range of national services. As a result, decision makers are often assessing far more than the capabilities of the application itself. They are considering how easily the product will fit within an already complex and interconnected environment.
This means interoperability can begin influencing adoption long before the first interface is developed.
From an NHS perspective, introducing a new solution rarely starts with the question of whether the software works. More often, the discussion begins with understanding how the software will fit into existing clinical pathways, what information will need to be shared and whether doing so will create additional complexity for already stretched teams. Where suppliers are unable to answer those questions clearly, uncertainty begins to emerge. Even when a product delivers substantial value, uncertainty can slow decision making because organisations naturally become concerned about implementation risk, future costs and operational disruption.
By contrast, suppliers who demonstrate a clear understanding of interoperability often create confidence much earlier in the conversation. This does not necessarily mean arriving with every technical detail already defined. More importantly, it means showing an awareness of the surrounding ecosystem, understanding where data originates, recognising where information needs to flow and appreciating the operational realities of working within NHS environments.
The distinction may seem subtle, but its impact can be significant.
We have seen suppliers invest enormous effort into refining product features while giving relatively little attention to how those features will integrate into existing workflows. The result can be a solution that performs exceptionally well in isolation but creates challenges when introduced into real-world clinical settings.
Clinicians may be required to duplicate data entry.
Operational teams may need to switch between multiple systems.
Information may become fragmented across different applications rather than being available where it is needed most.
None of these issues are necessarily caused by poor software design, yet they can have a profound impact on adoption because they directly affect the day-to-day experience of end users.
This is where interoperability begins to move beyond technology and become a business consideration.
Successful NHS adoption is often driven by confidence. Confidence that implementation can be delivered successfully. Confidence that staff can incorporate the solution into existing workflows. Confidence that information will be available where and when it is needed. Confidence that the product will remain viable as organisational requirements evolve. Interoperability contributes to each of these areas because it helps demonstrate that the solution has been designed to operate as part of a wider ecosystem rather than as a standalone application.
Another important consideration is that procurement teams, digital teams and clinical stakeholders frequently assess products from different perspectives. A clinician may focus primarily on patient outcomes and usability. A digital team may focus on architecture, standards and operational support. Procurement colleagues may focus on value, risk and long-term sustainability. Interoperability often acts as one of the few areas that touches all of these considerations simultaneously. Good interoperability can improve user experience, support information sharing, reduce operational overhead and provide confidence that future requirements can be accommodated without significant redevelopment.
As NHS organisations continue to pursue more integrated models of care, this becomes even more relevant.
Increasingly, patient journeys extend beyond individual organisations. Information needs to move between community services, acute trusts, primary care, mental health providers, social care partners and regional platforms. The ability to support those information flows is becoming an increasingly important consideration because organisations are no longer evaluating technology solely within the context of their own boundaries. They are looking at how technology contributes to wider system objectives and how effectively it supports collaboration across organisational lines.
For suppliers, this presents both a challenge and an opportunity.
The challenge is that interoperability can no longer be treated as an afterthought. Waiting until procurement is complete before considering information flows often introduces avoidable delays, additional costs and unnecessary complexity. The opportunity is that suppliers who engage with interoperability early frequently find themselves having more strategic conversations with potential customers. Rather than discussing interfaces as individual technical deliverables, they are able to demonstrate how their solution supports broader transformation objectives and fits naturally within the customer's operating environment.
Importantly, this does not mean every supplier needs a large interoperability team or a complex technical strategy. In many cases, NHS organisations are simply looking for evidence that interoperability has been considered properly. They want confidence that suppliers understand standards, recognise dependencies, appreciate governance considerations and have thought carefully about how information will move between systems. Practicality often matters more than perfection.
Ultimately, interoperability is unlikely to be the sole reason a solution is selected. NHS procurement decisions are influenced by numerous factors, many of which extend beyond technology. However, interoperability can significantly influence how confidently organisations approach those decisions and how successfully solutions are adopted once deployed.
The suppliers who tend to achieve the best outcomes are often those who recognise that NHS adoption is not merely about demonstrating what a product can do. It is about demonstrating how that product becomes part of a much larger environment, supports existing ways of working where appropriate, enables improvement where necessary and contributes positively to the wider flow of information across the health and care system.
That is where interoperability begins to influence adoption, not as a technical feature, but as an enabler of confidence, practicality and long-term success.
How Osprey Can Help
At Osprey, we have seen first-hand how interoperability influences adoption long before a solution reaches live operation. Many of the challenges suppliers encounter during NHS engagements are not caused by product capability, but by uncertainty around how the solution will fit into existing clinical, operational and technical environments. When interoperability is considered early, discussions tend to move beyond individual interfaces and towards understanding the wider role a solution will play in supporting patient care, service delivery and organisational objectives.
Our experience across NHS programmes has shown that successful adoption is rarely about connecting systems for the sake of connectivity. It is about enabling the right information to reach the right people at the right time, while reducing complexity for organisations that are already managing significant operational pressures. Suppliers who approach interoperability in this way often find that conversations become more strategic, implementation planning becomes more straightforward and confidence develops more quickly among stakeholders.
As integrated models of care continue to evolve, interoperability is becoming an increasingly important part of how NHS organisations assess the viability and long-term value of new solutions. Suppliers that recognise this early place themselves in a stronger position to support successful deployments and sustainable adoption.
At Osprey, we help suppliers navigate that journey by combining practical NHS experience with a clear understanding of the interoperability landscape. Whether supporting early planning, defining interface requirements or helping organisations deliver complex interoperability programmes, our focus is always the same: making interoperability practical, achievable and valuable for the people who depend on it.
Related Solution
Helping suppliers establish the foundations required for successful NHS adoption.
